MarketPulse
M

$MBRX

2 articles found
2 positive
0 negative
0 neutral
BenzingaBenzinga··Usanewsgroup.Com News Commentary

Cell Therapy Manufacturing Boom: $14B Market Opportunity Reshapes Biotech Landscape

Global cell therapy manufacturing market projected to reach $14B by 2035, with FDA regulatory flexibility accelerating approvals and multiple biotech companies advancing scalable production capabilities.
IBRXFATEMBRXAVAIGUTSCAR T-cell therapyMaster Cell Bank
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Moleculin Advances MIRACLE Study as Annamycin Shows Promise in AML Treatment

Moleculin Biotech releases CEO update on Phase 3 MIRACLE trial evaluating Annamycin for relapsed/refractory acute myeloid leukemia, with enrollment progressing on schedule.
MBRXclinical developmentPhase 3 trial